Association of thrombotic and fibrinolytic factors with severity of culprit lesion in patients with acute coronary syndromes without ST elevation

Southern Medical Journal

Volumn 103, Issue 4, 2010, Pages 289-294

  Turker, Yasin ^a,b,c   Dogan, Abdullah ^a,b,c   Ozaydin, Mehmet ^a,b,c   Kaya, Selcuk ^a,b,c   Onal, Suleyman ^a,b,c   Akkaya, Mehmet ^a,b,c   Erdogan, Dogan ^a,b,c  

^a Gulkent State Hospital   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c SIIRT STATE HOSPITAL   (Turkey)

Author keywords

Acute coronary syndromes; Culprit lesion; Prothrombin fragment 1 + 2; Thrombin antithrombin III complex

Indexed keywords

D DIMER; FIBRINOGEN; FIBRINOLYTIC FACTOR; PROTHROMBIN COMPLEX; PROTHROMBIN FRAGMENT 1; PROTHROMBIN FRAGMENT 2; THROMBIN ANTITHROMBIN COMPLEX; THROMBIN ANTITHROMBIN III COMPLEX; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; BLOOD FLOW; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; FEMALE; HEART INFARCTION; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; STENOSIS; THROMBOSIS; VASCULAR LESION;

ACUTE CORONARY SYNDROME; ANTITHROMBIN III; BIOLOGICAL MARKERS; CORONARY STENOSIS; ELECTROCARDIOGRAM PATTERN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; HUMANS; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROTHROMBIN; THROMBOSIS;

EID: 77953362976     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181ccb3d7     Document Type: Article

References (29)

1. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology; Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-1660.
2. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671.
3. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996;94:2013-2020.
4. Wilensky RL, Bourdillon PD, Vix VA, et al. Intracoronary artery thrombus formation in unstable angina: a clinical, biochemical and angiographic correlation. J Am Coll Cardiol 1993;21:692-699.
5. Ardissino D, Merlini PA, Bauer KA, et al. Coagulation activation and long-term outcome in acute coronary syndromes. Blood 2003;102:2731-2735.
6. Ernofsson M, Strekerud F, Toss H, et al. Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease. Thromb Haemost 1998;79:491-494.
7. Kruskal JB, Commerford PJ, Franks JJ, et al. Fibrin and fibrinogenrelated antigens in patients with stable and unstable coronary artery disease. N Engl J Med 1987;22:1361-1365.
8. Saigo M, Abe S, Ogawa M, et al. Imbalance of plasminogen activator inhibitor-I/tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction. Thromb Haemost 2001;86:1197-1203.
9. Gerotziafas GT, Zafiropoulos A, Van Dreden P, et al. Inhibition of factor VIIa generation and prothrombin activation by treatment with enoxaparin in patients with unstable angina. Br J Haematol 2003;120:611-617.
10. Merlini PA, Ardissino D, Oltrona L, et al. Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 1995;15:1675-1679.
11. Hoffmeister HM, Jur M, Helber U, et al. Correlation between coronary morphology and molecular markers of fibrinolysis in unstable angina pectoris. Atherosclerosis 1999;144:151-157.
12. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. The TIMI study group. N Engl J Med 1985;312:932-936.
13. Moss AJ, Goldstein RE, Marder VJ, et al. Thrombogenic factors and recurrent coronary events. Circulation 1999;99:2517-2522.
14. Hoffmeister HM, Jur M, Wendel HP, et al. Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris. Circulation 1995;91: 2520-2527.
15. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994;90:61-68.
16. Derhaschnig U, Laggner AN, Röggla M, et al. Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room. Clin Chem 2002;48:1924-1930.
17. Empana JP, Canoui-Poitrine F, Luc G, et al. PRIME Study Group. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study. Eur Heart J 2008;29:1966-1974.
18. Giannitsis E, Bardorff MM, Schweikart S, et al. Relationship of cardiac troponin T and procoagulant activity in unstable angina. Thromb Haemost 2000;83:224-228.
19. Terres W, Kümmel P, Sudrow A, et al. Enhanced coagulation activation in troponin T-positive unstable angina pectoris. Am Heart J 1998;135(2 Pt 1):281-286.
20. Morrow DA, Cannon CP, Rifai N, et al. TACTICS-TIMI 18 Investigators. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001;286:2405-2412.
21. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003;89:601-609.
22. Giannitsis E, Siemens HJ, Mitusch R, et al. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis. Int J Cardiol 1999; 68:269-274.
23. Bodí V, Sanchis J, Llàcer A, et al. Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine. Int J Cardiol 2005;98:277-283.
24. Saigo M, Hsue PY, Waters DD. Role of thrombotic and fibrinolytic factors in acute coronary syndromes. Prog Cardiovasc Dis 2004;46: 524-538.
25. Menown IB, Mathew TP, Gracey HM, et al. Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I Study. Prediction of recurrent events by D-dimer and Inflammatory markers in patients with normal cardiac troponin I (PREDICT) study. Am Heart J 2003;145:986-992.
26. Figueras J, Monasterio Y, Lidón RM, et al. Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest. J Am Coll Cardiol 2000;36:2036-2043.
27. Tello-Montoliu A, Marín F, Roldán V, et al. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Intern Med 2007;262:651-658.
28. Oldgren J, Linder R, Grip L, et al. Coagulation activity and clinical outcome in unstable coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:1059-1064.
29. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al. MERLINTIMI 36 Trial Investigators. Effects of ranolazine on recurrent cardiovascular events in patients with nonST-elevation acute coronary syndromes: the MERLIN-TIMI 36 Randomized Trial. JAMA 2007;297:1775-1783